---
title: "Carlsmed, Inc. (CARL) Gets a Buy from BTIG"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290616097.md"
description: "BTIG analyst Ryan Zimmerman maintained a Buy rating on Carlsmed, Inc. (CARL) with a $23 price target, despite shares closing at $9.84. The broader analyst consensus is a Strong Buy with an average target of $18.75. Zimmerman holds a 2-star rating with a 42.31% success rate."
datetime: "2026-06-23T21:40:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290616097.md)
  - [en](https://longbridge.com/en/news/290616097.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290616097.md)
generator: "portal-rs"
---

# Carlsmed, Inc. (CARL) Gets a Buy from BTIG

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Carlsmed, Inc., with a price target of $23.00. The company’s shares closed today at $9.84.

### TipRanks' Prime Week Sale - 70% Off

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Zimmerman is a 2-star analyst with an average return of 0.7% and a 42.31% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Glaukos, Solventum Corporation, and Intuitive Surgical.

Currently, the analyst consensus on Carlsmed, Inc. is a Strong Buy with an average price target of $18.75.

### Related Stocks

- [CARL.US](https://longbridge.com/en/quote/CARL.US.md)
- [GKOS.US](https://longbridge.com/en/quote/GKOS.US.md)
- [SOLV.US](https://longbridge.com/en/quote/SOLV.US.md)
- [ISRG.US](https://longbridge.com/en/quote/ISRG.US.md)

## Related News & Research

- [RealReal management to meet with BTIG](https://longbridge.com/en/news/298159892.md)
- [Saputo CEO Carl Colizza to present at Scotiabank Back to School Conference](https://longbridge.com/en/news/298470064.md)
- [ZIM (ZIM) Stock Looks Pricey On Earnings While Returns Stay Strong](https://longbridge.com/en/news/298399675.md)
- [These Analysts Revise Their Forecasts On Braze Following Upbeat Q2 Results](https://longbridge.com/en/news/298464524.md)
- [Jefferies Sticks to Their Buy Rating for Geberit AG (GEBN)](https://longbridge.com/en/news/298212922.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**